Vital Pulp Treatment in Primary Teeth



Status:Recruiting
Healthy:No
Age Range:2 - 9
Updated:5/4/2018
Start Date:November 2015
End Date:January 2020
Contact:Vineet Dhar, MDS, PhD
Email:vdhar@umaryland.edu
Phone:4107067970

Use our guide to learn which trials are right for you!

Evaluation of MTA Pulpotomy, Biodentine Pulpotomy, and Glass Ionomer Indirect Pulp Treatment in Primary Teeth

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy
or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves
removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the
remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is
to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the
treatment of deep decay in children's primary molars.

Pediatric patients having deep decay in primary molars seen at UMMC, UMSOD, and University of
Maryland Rehabilitation and Orthopaedic Institute, will be included in the sample. Teeth with
deep caries, >50% into dentin, will be randomly assigned using a table of random numbers to
the three treatment groups:

Group 1 pulpotomy with MTA, Group 2 pulpotomy with Biodentine, Group 3 indirect pulp
treatment. Treatment will be performed by board certified pediatric dentists or they will
directly supervise pediatric dental residents at each site as part of their regular protocol
for treating deep caries.

Radiographs will be taken as prescribed in the Guideline for taking Radiographs in Children
by the American Academy of Pediatric Dentistry.

Twice yearly clinical examinations will be performed by the treating dentists or pediatric
dental residents to check for any soft tissue pathology such as abscess or mobility of
treated tooth/teeth. If treatment success/failure consensus between the blinded dentists is
not reached, a third dentist will be consulted.

The success/failure data will be entered onto spreadsheets and examined statistically using
statistical software.

Inclusion Criteria:

- Pediatric patients with deep dental decay in primary molars

- Teeth with signs and symptoms of reversible pulpitis

Exclusion Criteria:

- Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental
infection

- Children with systemic illness that contraindicated vital pulp treatment such a sickle
cell disease

- Teeth that are not restorable
We found this trial at
1
site
?
mi
from
Baltimore, MD
Click here to add this to my saved trials